QTTB Q2 2023 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena

QTTBQ32 Bio Inc.

$73M

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+299.6% YoY

Gross Profit

$3M96.1% margin

Operating Income

-$7M-227.0% margin

Net Income

-$6M-181.2% margin

EPS (Diluted)

$-10.91

QoQ Revenue Growth

+8.8%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$2M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$169M

Total Liabilities

$50M

Stockholders' Equity

$119M

Cash & Equivalents

$77M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$802,000	+299.6%
Gross Profit	$3M	$16,000	+19156.3%
Operating Income	-$7M	-$28M	+74.3%
Net Income	-$6M	-$29M	+80.0%